Introduction
Deletion of the long arm of chromosome 4 has been reported with variable clinical findings including developmental delay and intellectual disability. We report an individual with a 4q35.2 deletion (1.2 Mb in size) detected by chromosomal microarray analysis which, to our knowledge, is the first individual with a submicroscopic interstitial deletion identifying three genes implicated in his clinical presentation and findings.
Clinical report
The proband was born to nonconsanguineous parents following a 33-week gestation complicated by maternal diabetes, alcohol use during the first trimester, and premature rupture of membranes. His apgar scores were 6 and 6 at 1 and 5 min, respectively, and his birth weight was 3.19 kg (25th centile). Because of respiratory distress, he received mechanical ventilation for 1 day following delivery and phototherapy for jaundice and hyperbilirubinemia until 6 days. A left cephalohematoma and bruising were reported at birth. His hematocrit on day 7 was 34.4. An echocardiogram at 2 days of age showed a large left-toright patent ductus arteriosus and a small left-to-right atrial shunt. Repeat echocardiogram at 6 days of age continued to show a patent ductus arteriosus, patent foramen ovale, right ventricular hypertrophy, flattened septum, tricuspid regurgitation, and mildly increased cardiac wall thickness. No surgical intervention was recommended. The head MRI scan was interpreted as normal. During early childhood, autism, attention-deficit hyperactivity disorder, obsessive-compulsive disorder, and intellectual disability were diagnosed along with posttraumatic stress disorder, self-injury, pica, and aggression. Sleep disturbances were identified by 3 years of age when he would not sleep until about 11:00 pm daily and for only 1-2 h at a time. He currently sleeps for only 4 h per night. The irregular sleep patterns were treated with melatonin but with limited success. His history of sensitivity to red food coloring and easy bruisability has been noted throughout his life. His developmental milestones were delayed with walking at 17 months and talking at 27 months. The Preschool Language Scale-3 was performed at the age of 32 months and he scored at the first percentile or an age equivalent of 10-12 months for auditory comprehension, expressive communication, and total language score. At the age of 4 years and 6 months, the Vineland Adaptive Behavior Scale showed age equivalent scores ranging from 17 months (socialization) to 32 months (motor skills). The Childhood Autism Rating Scale generated an overall score of 41 with a score greater than 36 consistent with autism. The Autism Diagnostic Observation Schedule-Generic generated an overall score of 15 with the cut-off score for autism being 12 or higher.
The hematogram at the age of 1 year showed a white blood cell count of 7300, red blood cell count of 5.19, hemoglobin of 14.1, hematocrit of 41.6, and platelet count of 217 000. At 4 years and 7 months, the hematogram was normal including a platelet count of 302 000. At 12 years his complete blood count was normal (platelets 198 K/ml), his electrolytes were normal, prothrombin time was normal at 13.7 s, and partial thromboplastin time, activated was normal at 31s.
Results
On physical examination at the age of 12 years and 9 months, he was quiet and cooperative with height 147.5 cm (20th centile), weight 37.6 kg (20th centile), and head circumference 52.5 cm (25th centile). Inner canthal distance was 3.4 cm (85th centile), outer canthal distance was 7.7 cm (10th centile), interpupillary distance was 5.7 cm (75th centile), and palpebral fissure length was 2.5 cm (25th centile). Ear length was 5.7 cm (40th centile). He had flattening of the right occiput compared with the left, which may be related to head positioning as an infant. His hair texture was coarse with an abnormal single posterior hair whorl. He manifested malar hypoplasia, brushfield spots, a short nose with anteverted nares, a smooth and flat philtrum, a thin upper lip, a broad mouth, and prognathism ( Fig. 1) . He had a high-arched palate. His hand length was 15.7 cm (10th centile) and middle finger length was 6.4 cm (10th centile). He had fifth finger clinodactyly, hyperflexible fingers, and shallow nail beds. He had short fifth toes bilaterally, left sided nail hypoplasia of the fifth toe, toe malalignment, and length discrepancy with toes on the right appearing longer than the toes on the left. A large ecchymotic area (6 Â 8 cm) was present on the right lateral knee area not related to recognized trauma or skin abrasion.
High resolution chromosome and fragile X DNA analyses were normal, but later, chromosomal microarray analysis was carried out clinically (CMDX laboratory, Irvine, California, USA) using the 105 K Oligo HD Scan to rule out microdeletions or microduplications. The microarray study showed a 1.2 Mb deletion (187.47-188.66 Mb from the p-terminus) of the chromosome 4q35.2 band, verified using fluorescence in-situ hybridization analysis (Fig. 2) . The patient's parents were unavailable for study.
Discussion
Interestingly, three genes are known to be located within the chromosome band including the melatonin receptor 1A (MTNR1A), a high affinity melatonin receptor that likely mediates melatonin receptors in the hypothalamic suprachiasmatic nucleus or site of the Frontal and profile facial views of the proband at the age of 12 years showing malar hypoplasia, a short nose with anteverted nares, a smooth and flat philtrum, a thin upper lip, prognathism, and a broad mouth. Note the ecchymotic area on the left cheek. circadian clock (Slaugenhaupt et al., 1995) . Wu et al. (2006) , reported that melatonin receptor 1A is expressed in many nuclei of the human hypothalamus, suggesting that melatonin may directly modulate hypothalamic physiological processes through this receptor. A disruption in this gene could lead to irregular and disruptive sleep patterns seen in the proband. The fat tumor suppressor (Drosophila) homolog 1 (FAT1) gene, located in this chromosome region, is involved in nerve cell adhesion and is part of the cadherin gene family, important in many developmental processes (Dunne et al., 1995) . Disturbance of the FAT1 gene is associated with both bipolar affective disorders and autism (Abou et al., 2008; Chien et al., 2010) . Although the assigned deletion includes both the MTNR1A and FAT1 genes, it is located very near to the 3 0 end of the F11 gene involved with blood coagulation and positioned at 187 187 118-187 210 835 bp. The F11 gene participates in blood coagulation as a catalyst in the conversion of factor XI to factor XIa in the presence of calcium ions (Asakai et al., 1987) . The F11 gene may be impacted by the deletion process as reported in other deletions of chromosome regions through disruption of cis-regulation of neighboring genes (Bittel et al., 2003 (Bittel et al., , 2005 . Loss of function of this gene may contribute to the history of easy bruisability in the proband and the large ecchymotic area observed during the examination.
Several other cases of terminal 4q deletions have been described including a 7-year-old nondysmorphic boy with mild intellectual disability reported by Balikova et al. (2007) due to a 4q35.2 qter deletion (about 1.3 Mb in size) detected with a 32 K Bacterial Artificial Chromosome array (see Table 1 for summary). In addition, array comparative genomic hybridization was used to identify a de-novo terminal deletion of the long arm of chromosome 4, del (4) Chien et al. (2010) with hypotonia during infancy and autism was found to have a 4q35.1-35.2 deletion, which included the region deleted in our proband. The above patients possessed distal 4q deletions that overlapped with the proband, but no reports of individuals with an interstitial deletion were identical to the deletion found in the proband.
One could speculate that the findings in the proband may fit the definition of a contiguous gene deletion syndrome as facial, cardiac, digital, and genital anomalies are often seen including Pierre-Robin sequence, cognitive, neurological, and behavioral problems. Fragile sites are reported in this chromosome region which may contribute to the deletion breakpoints (Sutherland and Hecht, 1985; Kahkonen 1988; Butler, 1998) . The authors encourage the reporting of other individuals with deletions involving the long arm of 4q to better define the clinical presentation and the use of chromosomal microarray studies for genotype-phenotype correlations.
